论文信息 - A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor in Patients with Myelofibrosis Refractory or Intolerant to JAK Inhibitors - 字舞流文

A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor in Patients with Myelofibrosis Refractory or Intolerant to JAK Inhibitors

M. Deininger | T. George | J. Prchal | K. Boucher | Soo Jin Kim | A. Pomicter | S. Tantravahi | K. Chamoun | Ami B Patel | J. Shah | A. Rets | Divya Sundar